Literature DB >> 9003757

The 2.8 A crystal structure of Gla-domainless activated protein C.

T Mather1, V Oganessyan, P Hof, R Huber, S Foundling, C Esmon, W Bode.   

Abstract

The structure of the Gla-domainless form of the human anticoagulant enzyme activated protein C has been solved at 2.8 A resolution. The light chain is composed of two domains: an epidermal growth factor (EGF)-like domain modified by a large insert containing an additional disulfide, followed by a typical EGF-like domain. The arrangement of the long axis of these domains describes an angle of approximately 80 degrees. Disulfide linked to the light chain is the catalytic domain, which is generally trypsin-like but contains a large insertion loop at the edge of the active site, a third helical segment, a prominent cationic patch analogous to the anion binding exosite I of thrombin and a trypsin-like Ca[II] binding site. The arrangement of loops around the active site partially restricts access to the cleft. The S2 and S4 subsites are much more polar than in factor Xa and thrombin, and the S2 site is unrestricted. While quite open and exposed, the active site contains a prominent groove, the surface of which is very polar with evidence for binding sites on the primed side, in addition to those typical of the trypsin class found on the non-primed side.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003757      PMCID: PMC452507     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  Contribution of residue 192 in factor Xa to enzyme specificity and function.

Authors:  A R Rezaie; C T Esmon
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

Review 2.  Thrombophilia: the discovery of activated protein C resistance.

Authors:  B Dahlbäck
Journal:  Adv Genet       Date:  1995       Impact factor: 1.944

3.  X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.

Authors:  H Brandstetter; M Bauer; R Huber; P Lollar; W Bode
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

4.  Alteration of the substrate and inhibitor specificities of blood coagulation factor VIIa: importance of amino acid residue K192.

Authors:  P F Neuenschwander; J H Morrissey
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

5.  The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.

Authors:  J Vijayalakshmi; K P Padmanabhan; K G Mann; A Tulinsky
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

6.  Treatment of purpura fulminans in meningococcemia with protein C concentrate.

Authors:  G E Rivard; M David; C Farrell; H P Schwarz
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

Review 7.  Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface.

Authors:  C T Esmon
Journal:  FASEB J       Date:  1995-07       Impact factor: 5.191

8.  The mechanism of inactivation of human factor V and human factor Va by activated protein C.

Authors:  M Kalafatis; M D Rand; K G Mann
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

9.  Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide.

Authors:  B W Grinnell; R B Hermann; S B Yan
Journal:  Glycobiology       Date:  1994-04       Impact factor: 4.313

10.  Glu192-->Gln substitution in thrombin yields an enzyme that is effectively inhibited by bovine pancreatic trypsin inhibitor and tissue factor pathway inhibitor.

Authors:  E R Guinto; J Ye; B F Le Bonniec; C T Esmon
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

View more
  64 in total

1.  Structure of human factor VIIa and its implications for the triggering of blood coagulation.

Authors:  A C Pike; A M Brzozowski; S M Roberts; O H Olsen; E Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.

Authors:  Lin Chen; Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

3.  The functional significance of the autolysis loop in protein C and activated protein C.

Authors:  Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2005-07       Impact factor: 5.249

4.  Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.

Authors:  Yao-Hsu Yang; Kwan-Ki Hwang; John FitzGerald; Jennifer M Grossman; Mihaela Taylor; Bevra H Hahn; Pojen P Chen
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

5.  Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.

Authors:  Changming Chen; Likui Yang; Bruno O Villoutreix; Xuefeng Wang; Qiulan Ding; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2017-04-13       Impact factor: 5.249

6.  Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome.

Authors:  Cai-Sheng Lu; Arash A Horizon; Kwan-Ki Hwang; John FitzGerald; Wei-Shiang Lin; Bevra H Hahn; Daniel J Wallace; Allan L Metzger; Michael H Weisman; Pojen P Chen
Journal:  Arthritis Rheum       Date:  2005-12

7.  Autolysis loop restricts the specificity of activated protein C: analysis by FRET and functional assays.

Authors:  Shabir H Qureshi; Chandrashekhara Manithody; Jong-Sup Bae; Likui Yang; Alireza R Rezaie
Journal:  Biophys Chem       Date:  2008-02-25       Impact factor: 2.352

8.  Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population.

Authors:  Qiulan Ding; Likui Yang; Seyed Mahdi Hassanian; A R Rezaie
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

9.  Contribution of factor VIII light-chain residues 2007-2016 to an activated protein C-interactive site.

Authors:  Masahiro Takeyama; Hironao Wakabayashi; Philip J Fay
Journal:  Thromb Haemost       Date:  2012-12-06       Impact factor: 5.249

10.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.